Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Sales (2017 - 2025)

Creative Medical Technology Holdings has reported Return on Sales over the past 9 years, most recently at 743.35% for Q4 2025.

  • Quarterly Return on Sales rose 24892.0% to 743.35% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1056.23% through Dec 2025, down 45476.0% year-over-year, with the annual reading at 1056.23% for FY2025, 45476.0% down from the prior year.
  • Return on Sales was 743.35% for Q4 2025 at Creative Medical Technology Holdings, up from 1180.69% in the prior quarter.
  • Over five years, Return on Sales peaked at 17.86% in Q3 2022 and troughed at 1180.69% in Q3 2025.
  • The 5-year median for Return on Sales is 266.42% (2021), against an average of 404.76%.
  • Biggest five-year swings in Return on Sales: soared 215364bps in 2021 and later plummeted -95334bps in 2025.
  • Tracing CELZ's Return on Sales over 5 years: stood at 57.2% in 2021, then tumbled by -484bps to 334.18% in 2022, then crashed by -67bps to 559.52% in 2023, then crashed by -77bps to 992.27% in 2024, then grew by 25bps to 743.35% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 743.35%, 1180.69%, and 1148.06% for Q4 2025, Q3 2025, and Q2 2025 respectively.